Position in RVMD
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$82,138,708
-$10,386,394 QoQ
Shares Held
844,614
-27.3% QoQ
Ownership
0.397%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 83.43586537755708.ToString("F0")%
Shared 15.989197432199798.ToString("F0")%
None 0.574937190243117.ToString("F0")%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,215,874 across 223 Biotechnology names. RVMD ranks #16 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in RVMD
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $82,138,708 | 844,614 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $92,525,102 | 1,161,646 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $67,286,197 | 1,440,818 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $36,647,399 | 996,124 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $13,215,941 | 373,754 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $16,961,278 | 387,775 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $17,889,350 | 394,473 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $15,158,526 | 390,583 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $42,906,476 | 1,331,259 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $51,492,672 | 1,795,421 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $46,000,366 | 1,661,863 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $44,639,757 | 1,668,776 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $34,872,315 | 1,609,987 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $27,390,448 | 1,149,893 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $18,468,094 | 936,516 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $12,292,282 | 630,697 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $12,213,575 | 478,776 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $4,539,157 | 180,340 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $753,774 | 27,400 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||